These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36342298)

  • 1. Systematic Analysis of IL-1 Cytokine Signaling Suppression by HPV16 Oncoproteins.
    Castagnino P; Kim HW; Lam LKM; Basu D; White EA
    J Virol; 2022 Nov; 96(22):e0132622. PubMed ID: 36342298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for direct interaction between the oncogenic proteins E6 and E7 of high-risk human papillomavirus (HPV).
    Lim J; Lilie H; Kalbacher H; Roos N; Frecot DI; Feige M; Conrady M; Votteler T; Cousido-Siah A; Corradini Bartoli G; Iftner T; Trave G; Simon C
    J Biol Chem; 2023 Aug; 299(8):104954. PubMed ID: 37354975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
    Khalil MI; Yang C; Vu L; Chadha S; Nabors H; James CD; Morgan IM; Pyeon D
    J Virol; 2024 Feb; 98(2):e0172623. PubMed ID: 38226814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection.
    Beachler DC; Viscidi R; Sugar EA; Minkoff H; Strickler HD; Cranston RD; Wiley DJ; Jacobson LP; Weber KM; Margolick JB; Reddy S; Gillison ML; D'Souza G
    Sex Transm Dis; 2015 Feb; 42(2):93-7. PubMed ID: 25585068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6/E7-expressing keratinocytes.
    Hyland PL; McDade SS; McCloskey R; Dickson GJ; Arthur K; McCance DJ; Patel D
    J Virol; 2011 Nov; 85(21):10999-1006. PubMed ID: 21865393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HPV16 E6, E7/miR-23b-3p/ICAT signaling axis promotes proliferation, migration, invasion and EMT of cervical cancer cells.
    Hu J; Liao D; Sun Z; Ren W; Zhao L; Fang Y; Hu K; Yu H; Liu S; Zhou L; He T; Zhang Y
    Carcinogenesis; 2023 May; 44(3):221-231. PubMed ID: 36847693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ErbB2/HER2 receptor tyrosine kinase regulates human papillomavirus promoter activity.
    Mikuličić S; Shamun M; Massenberg A; Franke AL; Freitag K; Döring T; Strunk J; Tenzer S; Lang T; Florin L
    Front Immunol; 2024; 15():1335302. PubMed ID: 38370412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis.
    Wei T; Grace M; Uberoi A; Romero-Masters JC; Lee D; Lambert PF; Munger K
    mBio; 2021 Aug; 12(4):e0227721. PubMed ID: 34465025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming Properties of Beta-3 Human Papillomavirus E6 and E7 Proteins.
    Minoni L; Romero-Medina MC; Venuti A; Sirand C; Robitaille A; Altamura G; Le Calvez-Kelm F; Viarisio D; Zanier K; Müller M; Accardi R; Tommasino M
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Papillomavirus 16 E2 Regulates Keratinocyte Gene Expression Relevant to Cancer and the Viral Life Cycle.
    Evans MR; James CD; Bristol ML; Nulton TJ; Wang X; Kaur N; White EA; Windle B; Morgan IM
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The difference of transcriptome of HPV-infected patients contributes more to the occurrence of cervical cancer than the mutations of E6 and E7 genes in HPV16.
    Zhang L; Li M; Yuan F; Jiang J; Zhang X
    Medicine (Baltimore); 2024 Jan; 103(3):e36822. PubMed ID: 38241590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational and AI-driven 3D structural analysis of human papillomavirus (HPV) oncoproteins E5, E6, and E7 reveal significant divergence of HPV E5 between low-risk and high-risk genotypes.
    Jones RN; Miyauchi S; Roy S; Boutros N; Mayadev JS; Mell LK; Califano JA; Venuti A; Sharabi AB
    Virology; 2024 Feb; 590():109946. PubMed ID: 38147693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NSP4 as adjuvant for immunogenicity and design of effective therapeutic HPV16 E6/E7/L1 DNA vaccine in tumor-bearing and healthy C57BL/6 mice.
    Sadr-Momtaz S; Aftabi M; Behboudi E; Naderi M; Hashemzadeh-Omran A; Moradi A
    BMC Res Notes; 2023 Aug; 16(1):164. PubMed ID: 37550734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Mechanisms of MmuPV1 E6 and E7 and Implications for Human Disease.
    Romero-Masters JC; Lambert PF; Munger K
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of high-risk HPV early oncoprotein (E6 and E7) serological markers in the detection of cervical cancer: A systematic review and meta-analysis.
    Singini MG; Singh E; Bradshaw D; Ramaliba T; Chen WC; Motlhale M; Kamiza AB; Babb de Villiers C; Muchengeti M; Mathew CG; Newton R; Bender N; Waterboer T; Sitas F
    J Med Virol; 2023 Jan; 95(1):e27900. PubMed ID: 35641882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics analysis of immune characteristics in tumors with alternative carcinogenesis pathways induced by human papillomaviruses.
    Smahel M; Nunvar J
    Virol J; 2023 Dec; 20(1):287. PubMed ID: 38049810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Papillomavirus E6 and E7 oncoproteins affect the cell microenvironment by classical secretion and extracellular vesicles delivery of inflammatory mediators.
    Iuliano M; Mangino G; Chiantore MV; Zangrillo MS; Accardi R; Tommasino M; Fiorucci G; Romeo G
    Cytokine; 2018 Jun; 106():182-189. PubMed ID: 29137858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.
    Westrich JA; Warren CJ; Klausner MJ; Guo K; Liu CW; Santiago ML; Pyeon D
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of HPV 16 and HPV 18 Oncoprotein Expression as Alternative Diagnostic Tools in Cervical Lesion.
    Sabri NA; Shamsuddin SH; Mat Zin AA
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):521-527. PubMed ID: 38415538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus E6 and E7 oncoproteins affect the expression of cancer-related microRNAs: additional evidence in HPV-induced tumorigenesis.
    Chiantore MV; Mangino G; Iuliano M; Zangrillo MS; De Lillis I; Vaccari G; Accardi R; Tommasino M; Columba Cabezas S; Federico M; Fiorucci G; Romeo G
    J Cancer Res Clin Oncol; 2016 Aug; 142(8):1751-63. PubMed ID: 27300513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.